Testing for everything

The B2C diagnostics market received a shot in the arm from the Covid-19 pandemic. As demand for PCR and LTF tests continues to subside, some are now using the extra cash earned during the last three years to invest in new consumer facing models Research included in the latest LaingBuisson report estimates the value of…

You must be a HM Subscriber to view this content.

Subscribe Now »